Venus Remedies Share Price (VENUSREM)
Check the latest share price of Venus Remedies, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Venus Remedies Stock Performance
Get live Venus Remedies share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹423.45Day's Price Range₹46752 Week's Low
52 Week's High
₹270.2552-Week Price Range₹476.9
| Returns % | |
| 1 Month Return | + 44.46 % |
| 3 Month Return | + 59.9 % |
| 1 Year Return | + 20.98 % |
| 3 Year Return | + 117.45 % |
| 5 Year Return | + 696 % |
| Market Stats | |
| Previous Close | ₹445.70 |
| Open | ₹437.90 |
| Volume | 50.23K |
| Upper Circuit | ₹467.95 |
| Lower Circuit | ₹423.45 |
Venus Remedies Fundamentals & Key Indicators
Check Venus Remedies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹611.27 Cr
Return on Equity (ROE)
6.18
PE Ratio (TTM)
13.48
Return on capital employed (ROCE)
8.61
Industry PE ratio
57.39
Beta (LTM)
0.83
P/B Ratio
0.86
Dividend Yield
0PEG Ratio
1.07
Quarterly Earnings Growth YOY
99.81
EPS (TTM)
21.31
Sector
Pharmaceuticals
Book Value
364.74
Technical Analysis
Bullish
View Technical Analysis
How to invest in Venus Remedies?
Investing in Venus Remedies is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Venus Remedies or VENUSREM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Venus Remedies or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Venus Remedies with just a few clicks!
Venus Remedies Stock's Interest Amongst Investors
Venus Remedies Valuation
Track how Venus Remedies P/E has moved over time to understand its valuation trends.
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (13.48x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 13.48x
Venus Remedies Financial Results
Get the annual and quarterly financial summary of Venus Remedies, including revenue, profit, loss and more.
Venus Remedies Earnings and Dividends
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit jumped 99.81% since last year same period to ₹21Cr in the Q4 2024-2025. On a quarterly growth basis, Venus Remedies Ltd has generated 7.14% jump in its net profits since last 3-months.
Read More about Earnings Results
Venus Remedies Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Venus Remedies.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1.34% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 56.9% | 0.00 | |
| Others | 0% | 0.00 |
Venus Remedies vs Peers
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 611.27 | 139.2% | 0.54 | 28 | 601 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Venus Remedies News & Key Events
Latest news and events in one place to help you make informed investing decisions in Venus Remedies.
Venus Remedies Reports Strong Financial Growth - 28 May, 2025
Venus Remedies reported a 10.78% increase in standalone net sales to Rs 194.04 crore for March 2025. Net profit rose 18.18% to Rs 14.79 crore, while EBITDA increased by 16.35%. The EPS also improved to Rs 11.07. The stock has delivered significant returns of 32.43% over the last six months and 35.50% over the past year.Venus Remedies Reports Strong Q4 Profit Growth - 27 May, 2025
Venus Remedies reported a 99.80% increase in Q4 FY25 net profit to Rs 21 crore, despite a slight decline in revenue. Full-year profit surged 59.07% to Rs 45.32 crore, reflecting strong operational performance.Venus Remedies Gains from GMP Certification Renewal - 22 May, 2025
Venus Remedies Ltd shares rose 1% after renewing its GMP certification from Ukraine's regulatory body for its Baddi facility. This renewal enhances the company's global presence and credibility, particularly in the growing Ukrainian pharmaceutical market, projected to reach $822.26 million by 2029.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 1.11% to 1.34% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 110.2 Cr → 201.73 Cr (in ₹), with an average increase of 16.7% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 1.22 Cr → 21.0 Cr (in ₹), with an average increase of 51.3% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, VENUSREM stock has moved up by 44.5%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 13.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 24.3%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 57.13% to 56.90% in Mar 2025 quarter
About Venus Remedies
Revenue: ₹194.97Cr as on March 2025 (Q4 FY25)
Net Profit: ₹21.00Cr as on March 2025 (Q4 FY25)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| CEO | Pawan Chaudhary |
| E-voting on shares | Click here to vote |
FAQs
What is Venus Remedies share price today?
Venus Remedies share price today stands at ₹457.3, Open: ₹437.9, Previous Close: ₹445.7, High: ₹467, Low: ₹423.45, 52 Week High: ₹476.9, 52 Week Low: ₹270.25.
What is today's traded volume of Venus Remedies?
Today's traded volume of Venus Remedies is 50.23K. Which means that 50.23K shares of Venus Remedies were bought and sold on the stock market during today's trading session.
What is Venus Remedies's market cap today?
Today's market capitalisation of Venus Remedies is ₹611.27 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Venus Remedies?
Venus Remedies’s 52 week high is ₹476.9 and 52 week low is ₹270.25. The current share price of Venus Remedies is ₹457.3, which is -4.11% down from its 52 week high and 69.21% up from its 52 week low.